The Oncology Institute, Inc. TOI Common stock, shares authorized (in shares)
Common stock, shares authorized (in shares) at other companies
Other financials
Where this comes from
Reported directly by The Oncology Institute, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.
The official record: The Oncology Institute, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about The Oncology Institute, Inc.'s common stock, shares authorized (in shares).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is The Oncology Institute, Inc.'s common stock, shares authorized (in shares)?
- The Oncology Institute, Inc. (TOI) reported common stock, shares authorized (in shares) of $500M in Q1 2026.
- How has The Oncology Institute, Inc.'s common stock, shares authorized (in shares) changed year-over-year?
- The Oncology Institute, Inc.'s common stock, shares authorized (in shares) decreased by 0.0% year-over-year, from $500M to $500M.
- What is the long-term trend for The Oncology Institute, Inc.'s common stock, shares authorized (in shares)?
- Over 4 years (2021 to 2025), The Oncology Institute, Inc.'s common stock, shares authorized (in shares) has grown at a 0.0% compound annual growth rate (CAGR), from $500M to $500M.